OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery
Younis Baqi, Christa E. Müller
Drug Discovery Today (2018) Vol. 24, Iss. 1, pp. 325-333
Closed Access | Times Cited: 52
Younis Baqi, Christa E. Müller
Drug Discovery Today (2018) Vol. 24, Iss. 1, pp. 325-333
Closed Access | Times Cited: 52
Showing 1-25 of 52 citing articles:
From purines to purinergic signalling: molecular functions and human diseases
Zhao Huang, Na Xie, Péter Illés, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 303
Zhao Huang, Na Xie, Péter Illés, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 303
Update of P2Y receptor pharmacology: IUPHAR Review 27
Kenneth A. Jacobson, Esmerilda G. Delicado, Christian Gachet, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 11, pp. 2413-2433
Open Access | Times Cited: 187
Kenneth A. Jacobson, Esmerilda G. Delicado, Christian Gachet, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 11, pp. 2413-2433
Open Access | Times Cited: 187
Carbohydrate-based drugs launched during 2000−2021
Xin Cao, Xiaojing Du, Heng Jiao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3783-3821
Open Access | Times Cited: 150
Xin Cao, Xiaojing Du, Heng Jiao, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 10, pp. 3783-3821
Open Access | Times Cited: 150
P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation
Alexandre Mansour, Christilla Bachelot‐Loza, Nicolas Nesseler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1391-1391
Open Access | Times Cited: 85
Alexandre Mansour, Christilla Bachelot‐Loza, Nicolas Nesseler, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 4, pp. 1391-1391
Open Access | Times Cited: 85
Molecular pharmacology of P2Y receptor subtypes
Ivar von Kügelgen
Biochemical Pharmacology (2020) Vol. 187, pp. 114361-114361
Closed Access | Times Cited: 74
Ivar von Kügelgen
Biochemical Pharmacology (2020) Vol. 187, pp. 114361-114361
Closed Access | Times Cited: 74
Exploring the diverse applications of Carbohydrate macromolecules in food, pharmaceutical, and environmental technologies
K Ramaprabha, S. Venkat Kumar, Panchamoorthy Saravanan, et al.
Environmental Research (2023) Vol. 240, pp. 117521-117521
Closed Access | Times Cited: 23
K Ramaprabha, S. Venkat Kumar, Panchamoorthy Saravanan, et al.
Environmental Research (2023) Vol. 240, pp. 117521-117521
Closed Access | Times Cited: 23
Pharmacology of P2Y receptors
Ivar von Kügelgen
Brain Research Bulletin (2019) Vol. 151, pp. 12-24
Closed Access | Times Cited: 69
Ivar von Kügelgen
Brain Research Bulletin (2019) Vol. 151, pp. 12-24
Closed Access | Times Cited: 69
Bridging free radical chemistry with drug discovery: A promising way for finding novel drugs efficiently
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2019) Vol. 189, pp. 112020-112020
Closed Access | Times Cited: 58
Zai‐Qun Liu
European Journal of Medicinal Chemistry (2019) Vol. 189, pp. 112020-112020
Closed Access | Times Cited: 58
Agonists and Antagonists for Purinergic Receptors
Christa E. Müller, Younis Baqi, Vigneshwaran Namasivayam
Methods in molecular biology (2019), pp. 45-64
Closed Access | Times Cited: 45
Christa E. Müller, Younis Baqi, Vigneshwaran Namasivayam
Methods in molecular biology (2019), pp. 45-64
Closed Access | Times Cited: 45
Recommended tool compounds and drugs for blocking P2X and P2Y receptors
Christa E. Müller, Vigneshwaran Namasivayam
Purinergic Signalling (2021) Vol. 17, Iss. 4, pp. 633-648
Open Access | Times Cited: 36
Christa E. Müller, Vigneshwaran Namasivayam
Purinergic Signalling (2021) Vol. 17, Iss. 4, pp. 633-648
Open Access | Times Cited: 36
Serotonin sensing by microglia conditions the proper development of neuronal circuits and of social and adaptive skills
Giulia Albertini, Ivana D’Andrea, Mélanie Druart, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2328-2342
Open Access | Times Cited: 16
Giulia Albertini, Ivana D’Andrea, Mélanie Druart, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 6, pp. 2328-2342
Open Access | Times Cited: 16
Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets
Kenneth A. Jacobson, Adriaan P. IJzerman, Christa E. Müller
Biochemical Pharmacology (2020) Vol. 187, pp. 114311-114311
Open Access | Times Cited: 36
Kenneth A. Jacobson, Adriaan P. IJzerman, Christa E. Müller
Biochemical Pharmacology (2020) Vol. 187, pp. 114311-114311
Open Access | Times Cited: 36
Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors
Li Yin, Kexin Ni, Tianqi Mao, et al.
Pharmacology & Therapeutics (2025), pp. 108802-108802
Closed Access
Li Yin, Kexin Ni, Tianqi Mao, et al.
Pharmacology & Therapeutics (2025), pp. 108802-108802
Closed Access
P2Y 12 R antagonists in antithrombotic therapy: a patent and literature review (2019–present)
Xinyu Chen, Kai Wang, Jie Jia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Xinyu Chen, Kai Wang, Jie Jia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Drug-like Antagonists of P2Y Receptor Subtypes: An Update
Mahesh Puthanveedu, Rebecca Knight, Michael J. Stocks
Journal of Medicinal Chemistry (2025)
Closed Access
Mahesh Puthanveedu, Rebecca Knight, Michael J. Stocks
Journal of Medicinal Chemistry (2025)
Closed Access
P2 Purinergic Signaling in the Distal Lung in Health and Disease
Eva Wirsching, Michael Fauler, Giorgio Fois, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4973-4973
Open Access | Times Cited: 32
Eva Wirsching, Michael Fauler, Giorgio Fois, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 4973-4973
Open Access | Times Cited: 32
Recent Advances in Microwave-Assisted Copper-Catalyzed Cross-Coupling Reactions
Younis Baqi
Catalysts (2020) Vol. 11, Iss. 1, pp. 46-46
Open Access | Times Cited: 28
Younis Baqi
Catalysts (2020) Vol. 11, Iss. 1, pp. 46-46
Open Access | Times Cited: 28
Pharmacological characterization of P2Y receptor subtypes – an update
Ivar von Kügelgen
Purinergic Signalling (2023) Vol. 20, Iss. 2, pp. 99-108
Open Access | Times Cited: 10
Ivar von Kügelgen
Purinergic Signalling (2023) Vol. 20, Iss. 2, pp. 99-108
Open Access | Times Cited: 10
PET imaging of neuroinflammation: any credible alternatives to TSPO yet?
Fabien Chauveau, Alexandra Winkeler, Sylvie Chalon, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 3
Fabien Chauveau, Alexandra Winkeler, Sylvie Chalon, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 3
Regioselective Homolytic C2–H Borylation of Unprotected Adenosine and Adenine Derivatives via Minisci Reaction
Yangyan Li, Yutong Zhou, Dazhi Zhou, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 31, pp. 21428-21441
Closed Access | Times Cited: 3
Yangyan Li, Yutong Zhou, Dazhi Zhou, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 31, pp. 21428-21441
Closed Access | Times Cited: 3
Synthesis and structure–activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39
Chunyang Bi, Laura Schäkel, Salahuddin Mirza, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106460-106460
Closed Access | Times Cited: 7
Chunyang Bi, Laura Schäkel, Salahuddin Mirza, et al.
Bioorganic Chemistry (2023) Vol. 135, pp. 106460-106460
Closed Access | Times Cited: 7
Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics
Yanshuo Guo, Tianqi Mao, Yafei Fang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Yanshuo Guo, Tianqi Mao, Yafei Fang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Clopidogrel drug interactions: a review of the evidence and clinical implications
Chang Hoon Lee, Francesco Franchi, Dominick J. Angiolillo
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1079-1096
Closed Access | Times Cited: 18
Chang Hoon Lee, Francesco Franchi, Dominick J. Angiolillo
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 11, pp. 1079-1096
Closed Access | Times Cited: 18
Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists
Maoqun Tian, Aliaa Abdelrahman, Younis Baqi, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 6164-6178
Closed Access | Times Cited: 17
Maoqun Tian, Aliaa Abdelrahman, Younis Baqi, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 6164-6178
Closed Access | Times Cited: 17
Clopidogrel Administration Impairs Post-Stroke Learning and Memory Recovery in Mice
Marina Paul, Jonathan Paúl, Madeleine Hinwood, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11706-11706
Open Access | Times Cited: 5
Marina Paul, Jonathan Paúl, Madeleine Hinwood, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11706-11706
Open Access | Times Cited: 5
